Carolina Wealth Advisors LLC Purchases 1,020 Shares of The Clorox Company (NYSE:CLX)

Carolina Wealth Advisors LLC grew its holdings in shares of The Clorox Company (NYSE:CLX) by 345.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,315 shares of the company’s stock after purchasing an additional 1,020 shares during the period. Carolina Wealth Advisors LLC’s holdings in Clorox were worth $214,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CLX. Prospera Private Wealth LLC purchased a new position in shares of Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Quarry LP raised its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares during the last quarter. Friedenthal Financial purchased a new position in Clorox in the 3rd quarter worth approximately $49,000. Finally, Catalyst Capital Advisors LLC purchased a new position in Clorox in the 3rd quarter worth approximately $54,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Down 0.4 %

Shares of NYSE CLX opened at $158.43 on Thursday. The firm’s 50-day moving average price is $164.48 and its 200-day moving average price is $156.16. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market capitalization of $19.61 billion, a price-to-earnings ratio of 55.20, a P/E/G ratio of 2.90 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 EPS. On average, equities research analysts anticipate that The Clorox Company will post 6.87 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.08%. Clorox’s dividend payout ratio is currently 170.03%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and boosted their price objective for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $157.46.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.